274 related articles for article (PubMed ID: 26391520)
1. Changing incidence of hyperammonemia in Japan from 2006 to 2013: expansion of new antiepileptic drugs reduces the risk of hyperammonemia.
Yamamoto Y; Takahashi Y; Imai K; Mishima N; Kagawa Y; Inoue Y
Eur J Clin Pharmacol; 2015 Dec; 71(12):1517-24. PubMed ID: 26391520
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hyperammonemia in pediatric patients with epilepsy.
Yamamoto Y; Takahashi Y; Imai K; Mishima N; Yazawa R; Inoue K; Itoh K; Kagawa Y; Inoue Y
Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients.
Yamamoto Y; Takahashi Y; Suzuki E; Mishima N; Inoue K; Itoh K; Kagawa Y; Inoue Y
Epilepsy Res; 2012 Sep; 101(3):202-9. PubMed ID: 22542569
[TBL] [Abstract][Full Text] [Related]
4. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
Tseng YL; Huang CR; Lin CH; Lu YT; Lu CH; Chen NC; Chang CC; Chang WN; Chuang YC
Medicine (Baltimore); 2014 Sep; 93(11):e66. PubMed ID: 25192484
[TBL] [Abstract][Full Text] [Related]
5. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
[TBL] [Abstract][Full Text] [Related]
6. [The decreased level of plasma carnitine in patients with epilepsy].
Belousova ED
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
[TBL] [Abstract][Full Text] [Related]
8. Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia.
Yagi M; Nakamura T; Okizuka Y; Oyazato Y; Kawasaki Y; Tsuneishi S; Sakaeda T; Matsuo M; Okumura K; Okamura N
Pediatr Int; 2010 Oct; 52(5):744-8. PubMed ID: 20456087
[TBL] [Abstract][Full Text] [Related]
9. 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.
Inoue K; Suzuki E; Takahashi T; Yamamoto Y; Yazawa R; Takahashi Y; Imai K; Miyakawa K; Inoue Y; Tsuji D; Hayashi H; Itoh K
Epilepsy Res; 2014 Aug; 108(6):1046-51. PubMed ID: 24888247
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands.
van de Vrie-Hoekstra NW; de Vries TW; van den Berg PB; Brouwer OF; de Jong-van den Berg LT
Eur J Clin Pharmacol; 2008 Oct; 64(10):1013-20. PubMed ID: 18618103
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Presentation, and Risk Factors for Sodium Valproate-Associated Hyperammonemia in Neurosurgical Patients: A Prospective, Observational Study.
Woo PYM; Woo AWY; Lam SW; Ko NMW; Ho JWK; Chu ACH; Kwan MCL; Chan Y; Wong HT; Chan KY
World Neurosurg; 2020 Dec; 144():e597-e604. PubMed ID: 32916358
[TBL] [Abstract][Full Text] [Related]
12. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
Knudsen JF; Sokol GH; Flowers CM
J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
[TBL] [Abstract][Full Text] [Related]
17. Fracture risk associated with use of antiepileptic drugs.
Vestergaard P; Rejnmark L; Mosekilde L
Epilepsia; 2004 Nov; 45(11):1330-7. PubMed ID: 15509233
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of antiepileptic drug use in pregnant Australian women.
Vajda FJ; Hollingworth S; Graham J; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
Acta Neurol Scand; 2010 Feb; 121(2):89-93. PubMed ID: 20015108
[TBL] [Abstract][Full Text] [Related]
19. Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy.
Contin M; Bisulli F; Santucci M; Riva R; Tonon F; Mohamed S; Ferri L; Stipa C; Tinuper P;
Epilepsia; 2018 Jul; 59(7):e103-e108. PubMed ID: 29897632
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
